el Din M M, Malik K U
Department of Pharmacology, College of Medicine, University of Tennessee, Memphis.
J Pharmacol Exp Ther. 1988 Aug;246(2):479-84.
We have investigated the effects of neuropeptide Y (NPY) on vascular tone and renal output of prostaglandins (PGs) and the mechanism underlying these actions by examining the effects of Ca++ depletion, Ca++ channel blockers and calmodulin inhibitors in the isolated Tyrode's perfused rat kidney. Administration of NPY (0.23-2.3 nmol) into the kidney produced a dose-related renal vasoconstriction and an increase in the output of PGE2 and 6-keto-PGF1 alpha, the stable hydrolysis product of PGI2. Omission of Ca++ (1.8 mM) or addition of Ca++ channel blockers, diltiazem (60 microM) or nifedipine (1.4 microM), to the perfusion fluid abolished the effects of NPY to promote renal vasoconstriction and PG synthesis. Infusion of calmodulin inhibitors, trifluoperazine (2 microM), W-7 [N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide] (20 microM) or calmidazolium (0.2 microM), attenuated the renal vasoconstriction and the increase in PG output produced by NPY (0.7 nmol). In kidneys perfused with normal Tyrode's solution, infusion of NPY, in a concentration (1.7 X 10(-8) M) that produced only a small transient increase in renal vascular tone and failed to alter the renal output of PGs, enhanced the rise in PGE2 and 6-keto-PGF1 alpha elicited by norepinephrine (0.25 nmol) but not by arginine vasopressin (0.004 nmol) or angiotensin II (0.09 nmol). The renal vasoconstriction elicited by norepinephrine and arginine vasopressin as well as by angiotensin II was enhanced by NPY.(ABSTRACT TRUNCATED AT 250 WORDS)
我们通过检测钙离子耗竭、钙离子通道阻滞剂和钙调蛋白抑制剂对离体台氏液灌注大鼠肾脏的影响,研究了神经肽Y(NPY)对血管张力及前列腺素(PGs)肾输出量的影响以及这些作用的潜在机制。向肾脏内注射NPY(0.23 - 2.3 nmol)可产生剂量相关的肾血管收缩,并使PGE2和6-酮-PGF1α(PGI2的稳定水解产物)的输出量增加。灌注液中去除钙离子(1.8 mM)或添加钙离子通道阻滞剂地尔硫卓(60 μM)或硝苯地平(1.4 μM)可消除NPY促进肾血管收缩和PG合成的作用。输注钙调蛋白抑制剂三氟拉嗪(2 μM)、W-7 [N-(6-氨基己基)-5-氯-1-萘磺酰胺](20 μM)或卡米达唑(0.2 μM)可减弱NPY(0.7 nmol)引起的肾血管收缩及PG输出量增加。在灌注正常台氏液的肾脏中,输注浓度为(1.7×10⁻⁸ M)的NPY,其仅使肾血管张力产生轻微短暂升高且未改变PG的肾输出量,但可增强去甲肾上腺素(0.25 nmol)引起的PGE2和6-酮-PGF1α升高,而对精氨酸血管加压素(0.004 nmol)或血管紧张素II(0.09 nmol)引起的升高无增强作用。去甲肾上腺素、精氨酸血管加压素以及血管紧张素II引起的肾血管收缩均被NPY增强。(摘要截短于250字)